Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP119 and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)
- 1 July 2006
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 8 (8) , 2130-2137
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Revisiting Freund's incomplete adjuvant for vaccines in the developing worldTrends in Parasitology, 2005
- Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearanceBlood, 2005
- Pre-clinical evaluation of the malaria vaccine candidate . MSP1 formulated with novel adjuvants or with alumVaccine, 2004
- The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidateImmunology Letters, 2004
- Plasmodium vivaxPromiscuous T-Helper Epitopes Defined and Evaluated as Linear Peptide Chimera ImmunogensInfection and Immunity, 2002
- Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectorsVaccine, 2001
- Efficacy of Two Alternate Vaccines Based onPlasmodium falciparumMerozoite Surface Protein 1 in anAotusChallenge TrialInfection and Immunity, 2001
- Major histocompatibility complex class II polymorphisms in primatesImmunological Reviews, 1999
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.Journal of Experimental Medicine, 1990
- Solid‐phase peptide synthesis: a practical approachFEBS Letters, 1990